Skip to main navigation

MRIdian Locator
Investors
Toolkit
Customer Portal

Menu

MRIdian Locator
Investors
Toolkit
Customer Portal

MRIdian
For Patients
- Patient Success Stories
- Cancers Treated by MRIdian
For Clinicians
About Us
Careers
- Our Culture & Benefits
- Working at ViewRay

Menu

MRIdian
For Patients
- Patient Success Stories
- Cancers Treated by MRIdian
For Clinicians
About Us
Careers
- Our Culture & Benefits
- Working at ViewRay

Investor Relations

Investors Overview
Stock Information
Financial Information
- Quarterly Results
- SEC Filings
Financial News
Events & Webinars
Governance
Investor Resources

Financial News

Year

ViewRay Announces Conference Call for First Quarter 2022 Financial Results to be Held After Market on May 5, 2022

April 21, 2022

PDF Version

Read More

University Hospital Agostino Gemelli Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy

March 15, 2022

PDF Version

Read More

ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on March 16, 2022

March 10, 2022

PDF Version

Read More

First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer

March 10, 2022

PDF Version

Read More

ViewRay Enters into Cooperation Agreement with Hudson Executive Capital

March 9, 2022

PDF Version

Read More

Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul

March 3, 2022

PDF Version

Read More

ViewRay Announces Fourth Quarter and Full Year 2021 Results

February 24, 2022

PDF Version

Read More

Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

February 15, 2022

PDF Version

Read More

ViewRay® to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 10, 2022

PDF Version

Read More

ViewRay Announces Conference Call for Fourth Quarter and Full Year 2021 Financial Results to be Held After Market on February 24, 2022

February 10, 2022

PDF Version

Read More

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Request E-mail Alerts Submit

1099 18th Street, Ste 3000
Denver, CO 80202

815 E Middlefield Rd
Mountain View, CA 94043

2 Thermo Fisher Way
Oakwood Village, OH 44146

Facebook-f Twitter Youtube Instagram Linkedin

MRIdian

footer nav col1

Discover MRIdian
MRIdian A3i System
MRIdian Programs
MRIdian Treatment Centers

Menu

footer nav col1

Discover MRIdian
MRIdian A3i System
MRIdian Programs
MRIdian Treatment Centers

For Patients

footer nav col2

Patient Stories
Types of Cancers MRIdian Treats

Menu

footer nav col2

Patient Stories
Types of Cancers MRIdian Treats

For Clinicians

footer nav col3

Clinical Trials
Investigator-Initiated Research
Medical Affairs
Scientific Presentations
MRIdian Webinars

Menu

footer nav col3

Clinical Trials
Investigator-Initiated Research
Medical Affairs
Scientific Presentations
MRIdian Webinars

About Us

footer nav col4

Leadership
Press Releases
Media Kit
Contact Us
Cigna Compliance
Cigna Model Notice
Safety
Privacy
Legal
Investors

Menu

footer nav col4

Leadership
Press Releases
Media Kit
Contact Us
Cigna Compliance
Cigna Model Notice
Safety
Privacy
Legal
Investors

Careers

Our Culture & Benefits
Working at ViewRay

Menu

Our Culture & Benefits
Working at ViewRay

© 2023 ViewRay, Inc. (“ViewRay”). All Rights Reserved.